A Randomized, Double-blind, Single-dosing, Crossover Study to Compare the Safety and Pharmacokinetic Characteristics of HD203 25 mg With Those of Enbrel Injection 25 mg After Subcutaneous Injection in Healthy Male Volunteers
Phase of Trial: Phase I
Latest Information Update: 18 Jul 2016
At a glance
- Drugs Etanercept (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacokinetics
- Acronyms EAGLE-I-13
- Sponsors Hanwha Chemical
- 12 Jul 2016 Status changed from active, no longer recruiting to completed.
- 12 Nov 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 14 Aug 2013 New trial record